title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"ADCT Awaits Cami Trial Data, CSTL Boosts Revenue Outlook, ANNX To Report HD Trial Data In Q2",20220510T094515,https://markets.businessinsider.com/news/stocks/adct-awaits-cami-trial-data-cstl-boosts-revenue-outlook-annx-to-report-hd-trial-data-in-q2-1031440845,CSTL,0.065452,Neutral,0.083871
Stocks That Hit 52-Week Lows On Monday,20220418T154044,https://www.benzinga.com/news/22/04/26669813/stocks-that-hit-52-week-lows-on-monday,CSTL,0.005428,Neutral,0.003205
Incyte's Late-stage NSCLC Study Meets Primary and Secondary Goals,20241209T181400,https://www.zacks.com/stock/news/2381136/incytes-late-stage-nsclc-study-meets-primary-and-secondary-goals,CSTL,0.211191,Neutral,0.103535
"EPAM Systems, Amyris, Blueprint Medicines And Other Big Stocks Moving Lower On Monday - Amyris  ( NASDAQ:AMRS ) , DMC Glb  ( NASDAQ:BOOM ) ",20230605T153030,https://www.benzinga.com/news/23/06/32718538/epam-systems-amyris-blueprint-medicines-and-other-big-stocks-moving-lower-on-monday,CSTL,0.245339,Somewhat-Bullish,0.237652
